201 related articles for article (PubMed ID: 26033683)
1. p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1.
Yun J; Espinoza I; Pannuti A; Romero D; Martinez L; Caskey M; Stanculescu A; Bocchetta M; Rizzo P; Band V; Band H; Kim HM; Park SK; Kang KW; Avantaggiati ML; Gomez CR; Golde T; Osborne B; Miele L
J Cell Physiol; 2015 Dec; 230(12):3115-27. PubMed ID: 26033683
[TBL] [Abstract][Full Text] [Related]
2. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional mechanisms by the coregulator MAML1.
Saint Just Ribeiro M; Wallberg AE
Curr Protein Pept Sci; 2009 Dec; 10(6):570-6. PubMed ID: 19751190
[TBL] [Abstract][Full Text] [Related]
4. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
[TBL] [Abstract][Full Text] [Related]
5. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.
Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C
J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525
[TBL] [Abstract][Full Text] [Related]
7. The notch regulator MAML1 interacts with p53 and functions as a coactivator.
Zhao Y; Katzman RB; Delmolino LM; Bhat I; Zhang Y; Gurumurthy CB; Germaniuk-Kurowska A; Reddi HV; Solomon A; Zeng MS; Kung A; Ma H; Gao Q; Dimri G; Stanculescu A; Miele L; Wu L; Griffin JD; Wazer DE; Band H; Band V
J Biol Chem; 2007 Apr; 282(16):11969-81. PubMed ID: 17317671
[TBL] [Abstract][Full Text] [Related]
8. Detrimental effects of Notch1 signaling activated by cadmium in renal proximal tubular epithelial cells.
Fujiki K; Inamura H; Matsuoka M
Cell Death Dis; 2014 Aug; 5(8):e1378. PubMed ID: 25118938
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers.
Buckley NE; Nic An tSaoir CB; Blayney JK; Oram LC; Crawford NT; D'Costa ZC; Quinn JE; Kennedy RD; Harkin DP; Mullan PB
Nucleic Acids Res; 2013 Oct; 41(18):8601-14. PubMed ID: 23863842
[TBL] [Abstract][Full Text] [Related]
10. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways.
Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y
Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142
[TBL] [Abstract][Full Text] [Related]
12. A study on Notch signaling in human breast cancer.
Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
14. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
[TBL] [Abstract][Full Text] [Related]
15. High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.
Izrailit J; Berman HK; Datti A; Wrana JL; Reedijk M
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1714-9. PubMed ID: 23319603
[TBL] [Abstract][Full Text] [Related]
16. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.
Shimizu M; Cohen B; Goldvasser P; Berman H; Virtanen C; Reedijk M
Cancer Res; 2011 Jan; 71(1):277-86. PubMed ID: 21199807
[TBL] [Abstract][Full Text] [Related]
18. Soluble Jagged-1 inhibits neointima formation by attenuating Notch-Herp2 signaling.
Caolo V; Schulten HM; Zhuang ZW; Murakami M; Wagenaar A; Verbruggen S; Molin DG; Post MJ
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1059-65. PubMed ID: 21330605
[TBL] [Abstract][Full Text] [Related]
19. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
Tonon G; Modi S; Wu L; Kubo A; Coxon AB; Komiya T; O'Neil K; Stover K; El-Naggar A; Griffin JD; Kirsch IR; Kaye FJ
Nat Genet; 2003 Feb; 33(2):208-13. PubMed ID: 12539049
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 by jagged1 contributes to angiotensin II-induced impairment of myocardial angiogenesis.
Guan A; Gong H; Ye Y; Jia J; Zhang G; Li B; Yang C; Qian S; Sun A; Chen R; Ge J; Zou Y
PLoS One; 2013; 8(10):e76529. PubMed ID: 24098521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
